These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 26699290

  • 1. Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy.
    Dhanesar SK, Lim TY, Du W, Bruno TL, Frank SJ, Kudchadker RJ.
    J Appl Clin Med Phys; 2015 Sep 08; 16(5):62–75. PubMed ID: 26699290
    [Abstract] [Full Text] [Related]

  • 2. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
    Ballester F, Carlsson Tedgren Å, Granero D, Haworth A, Mourtada F, Fonseca GP, Zourari K, Papagiannis P, Rivard MJ, Siebert FA, Sloboda RS, Smith RL, Thomson RM, Verhaegen F, Vijande J, Ma Y, Beaulieu L.
    Med Phys; 2015 Jun 08; 42(6):3048-61. PubMed ID: 26127057
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P, Stea L, Cattani F, Lappi S, Giglioli F, Calamia E, Ziglio F, Martinelli R, Longobardi B.
    Radiother Oncol; 2004 Apr 08; 71(1):13-21. PubMed ID: 15066291
    [Abstract] [Full Text] [Related]

  • 4. Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants.
    Nuñez-Cumplido E, Perez-Calatayud J, Casares-Magaz O, Hernandez-Armas J.
    Med Phys; 2015 Aug 08; 42(8):4933-40. PubMed ID: 26233219
    [Abstract] [Full Text] [Related]

  • 5. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
    Chiu-Tsao ST, Astrahan MA, Finger PT, Followill DS, Meigooni AS, Melhus CS, Mourtada F, Napolitano ME, Nath R, Rivard MJ, Rogers DW, Thomson RM.
    Med Phys; 2012 Oct 08; 39(10):6161-84. PubMed ID: 23039655
    [Abstract] [Full Text] [Related]

  • 6. Monte Carlo investigation of I-125 interseed attenuation for standard and thinner seeds in prostate brachytherapy with phantom validation using a MOSFET.
    Mason J, Al-Qaisieh B, Bownes P, Henry A, Thwaites D.
    Med Phys; 2013 Mar 08; 40(3):031717. PubMed ID: 23464312
    [Abstract] [Full Text] [Related]

  • 7. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
    Mashouf S, Safigholi H, Merino T, Soliman A, Ravi A, Morton G, Song WY.
    Brachytherapy; 2016 Mar 08; 15(6):774-779. PubMed ID: 27720310
    [Abstract] [Full Text] [Related]

  • 8. Development of a phantom to validate high-dose-rate brachytherapy treatment planning systems with heterogeneous algorithms.
    Moura ES, Micka JA, Hammer CG, Culberson WS, DeWerd LA, Rostelato ME, Zeituni CA.
    Med Phys; 2015 Apr 08; 42(4):1566-74. PubMed ID: 25832047
    [Abstract] [Full Text] [Related]

  • 9. DVH-Based Inverse Planning Using Monte Carlo Dosimetry for LDR Prostate Brachytherapy.
    Mountris KA, Visvikis D, Bert J.
    Int J Radiat Oncol Biol Phys; 2019 Feb 01; 103(2):503-510. PubMed ID: 30315873
    [Abstract] [Full Text] [Related]

  • 10. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate 192 Ir brachytherapy.
    Ma Y, Vijande J, Ballester F, Tedgren ÅC, Granero D, Haworth A, Mourtada F, Fonseca GP, Zourari K, Papagiannis P, Rivard MJ, Siebert FA, Sloboda RS, Smith R, Chamberland MJP, Thomson RM, Verhaegen F, Beaulieu L.
    Med Phys; 2017 Nov 01; 44(11):5961-5976. PubMed ID: 28722180
    [Abstract] [Full Text] [Related]

  • 11. Addendum to brachytherapy dose-volume histogram commissioning with multiple planning systems.
    Gossman MS.
    J Appl Clin Med Phys; 2016 May 08; 17(3):502-505. PubMed ID: 27167288
    [Abstract] [Full Text] [Related]

  • 12. New approach of ultra-focal brachytherapy for low- and intermediate-risk prostate cancer with custom-linked I-125 seeds: A feasibility study of optimal dose coverage.
    Brun T, Bachaud JM, Graff-Cailleaud P, Malavaud B, Portalez D, Popotte C, Aziza R, Lusque A, Filleron T, Ken S.
    Brachytherapy; 2018 May 08; 17(3):544-555. PubMed ID: 29525514
    [Abstract] [Full Text] [Related]

  • 13. Brachytherapy dose-volume histogram commissioning with multiple planning systems.
    Gossman MS, Hancock SS, Kudchadker RJ, Lundahl PR, Cao M, Melhus CS.
    J Appl Clin Med Phys; 2014 Mar 06; 15(2):4620. PubMed ID: 24710449
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of dosimetric effects of metallic artifact reduction and tissue assignment on Monte Carlo dose calculations for 125 I prostate implants.
    Assam I, Vijande J, Ballester F, Pérez-Calatayud J, Poppe B, Siebert FA.
    Med Phys; 2022 Sep 06; 49(9):6195-6208. PubMed ID: 35925023
    [Abstract] [Full Text] [Related]

  • 15. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
    Bannon EA, Yang Y, Rivard MJ.
    Med Phys; 2011 Jun 06; 38(6):2957-63. PubMed ID: 21815369
    [Abstract] [Full Text] [Related]

  • 16. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S, Nedaie HA, Sadeghi M, Pourbeigy H, Shahzadi S, Zehtabian M, Hasani M, Meigooni AS.
    J Appl Clin Med Phys; 2016 Jul 08; 17(4):430-441. PubMed ID: 27455485
    [Abstract] [Full Text] [Related]

  • 17. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
    Rivard MJ, Melhus CS, Granero D, Perez-Calatayud J, Ballester F.
    Med Phys; 2009 Jun 08; 36(6):1968-75. PubMed ID: 19610285
    [Abstract] [Full Text] [Related]

  • 18. Dosimetric and radiobiological investigation of permanent implant prostate brachytherapy based on Monte Carlo calculations.
    Haidari AM, Miksys N, Soubiran P, Cygler JE, Holmes O, Perry G, Thomson RM.
    Brachytherapy; 2019 Jun 08; 18(6):875-882. PubMed ID: 31400953
    [Abstract] [Full Text] [Related]

  • 19. Dosimetry modeling for focal high-dose-rate prostate brachytherapy.
    Mason J, Al-Qaisieh B, Bownes P, Thwaites D, Henry A.
    Brachytherapy; 2014 Jun 08; 13(6):611-7. PubMed ID: 25085456
    [Abstract] [Full Text] [Related]

  • 20. Investigation of interseed attenuation and tissue composition effects in (125)I seed implant prostate brachytherapy.
    Mason J, Al-Qaisieh B, Bownes P, Henry A, Thwaites D.
    Brachytherapy; 2014 Jun 08; 13(6):603-10. PubMed ID: 24913435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.